Indication: Registry
Laser Ablation of Abnormal Neurological Tissue using Robotic Neuroblate system (LAANTERN) Prospective Registry
Sub-indication: CNS Cancer
Study Type: Registry
Principal Investigator: David Sun, M.D.Norton Brain Tumor Center
Sponsor: Sponsor: Monteris Medical Corporation
Learn more at ClinicalTrials.gov
Email for more information: CNS-NCIResearch@nortonhealthcare.org
